Beam Therapeutics (BEAM) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Beam Therapeutics Inc.'s (NASDAQ:BEAM) Price Is Right But Growth Is Lacking After Shares Rocket 39%
Simply Wall StFeb 15 07:16 ET
Cathie Wood's Ark Invest Loads Up On Iridium, Twist Bioscience, Offloads Roku: Here Are Key Ark Trades This Friday
BenzingaFeb 15 05:24 ET
Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Friday
BenzingaFeb 14 12:24 ET
$BEAM Stock Is up 16% Today. Here's What We See in Our Data.
Quiver QuantitativeFeb 14 10:31 ET
Moderna (MRNA) Reports Q4 Loss, Tops Revenue Estimates
Zacks Feb 14 06:50 ET
Wall Street Analysts See a 67.27% Upside in Beam Therapeutics (BEAM): Can the Stock Really Move This High?
Zacks Feb 13 09:00 ET

Comments

Analysts Notebook

Feb 13 05:50

Columns Interest in AI-Powered MedTech is on the Rise: Key Stocks to Watch

The attention of AI Medteck stocks are rapidly increasing.
Pelosi's new holdings have doubled $Tempus AI (TEM.US)$ value in just a few weeks, and $Firefly Neuroscience (AIFF.US)$'s inclusion in NVIDIA's Connect program has also caused its stock price to soar.
In addition, DeepSeek's rapid rise has boosted the AI application sector, particularly in medicine/healthcare. Cathie Wood believes medical AI is undervalued, with untapped pot...

104

11

248

Moomoo News Global

Feb 6 03:43

Columns AI Healthcare-tech May Be the Next Big Thing. Here's Why

US Congress member Nancy Pelosi and Ark Invest's Cathie Wood both bet big on an AI stock recently.
The stock in question is $Tempus AI (TEM.US)$, a company that uses data and artificial intelligence (AI) to create precision medicine services. ARK Invest, a prominent advocate for innovative technologies, first showed interest on December 6, when it purchased shares in this healthcare technology firm. Since that initial investment, Tempus AI h...

45

7

151

This_Guy

Dec 8, 2024 17:16

$Beam Therapeutics (BEAM.US)$
Beam Therapeutics Presents New Non-human Primate (NHP) Data Demonstrating Proof-of-concept for ESCAPE, a Non-genotoxic, Antibody-based Conditioning Approach to Treating Sickle Cell Disease, at American Society of Hematology (ASH) Annual Meeting
Beam Therapeutics (NASDAQ: BEAM) presented new data for its ESCAPE conditioning platform at the ASH Annual Meeting. The data demonstrated successful proof-of-concept in non-human primates (NHPs) for a non-genotoxic conditionin...

1

Moomoo News Global

Sep 10, 2024 08:28

Columns Here's What the Harris-Trump Debate Means for US Stocks

As the U.S. presidential election approaches in just two months, focus intensifies on the crucial debate between Vice President Kamala Harris and former President Donald Trump, scheduled for 9 p.m. ET on Tuesday, September 10. For investors strategizing around the "Trump trade" or the "Harris trade," the market's forward-looking reaction to their governing policies is critical. The election outcome will shape expectations of their administra...